Abordagem terapêutica das vasculites pulmonares / Therapeutic approach to pulmonary vasculitis
Pulmäo RJ
;
23(2): 27-31, 2014. tab
Article
in Portuguese
| LILACS
| ID: lil-727914
RESUMO
Muitas vasculites sistêmicas acometem o trato respiratório. O acometimento mais frequente é o do parênquima pulmonar pelas vasculites de pequenos vasos ANCA associadas (antineutrophil cytoplasmic antibodies), que incluem a granulomatose com poliangite (GPA, antiga granulomatose de Wegener), a poliangite microscópica (MPA), granulomatose eosinofílica com poliangite (EGPA, antiga doença de Churg-Strauss). Este artigo propõe-se a revisar o tratamento dessas doenças de acordo com recomendações da liga europeia de combate ao reumatismo (EULAR), com base no estádio e na atividade de doença, incluindo as terapia usadas na indução e na manutenção de remissão, assim como nos casos refratários ao tratamento convencional
ABSTRACT
There are many vasculitis that affect the respiratory tract. The pulmonary parenchyma is the most frequently involved and occurs mainly in ANCA associated small vessel vasculitis (antineutrophil cytoplasmic antibodies), which include granulomatosis with polyangitis (GPA, formely Wegener's granulomatosis), microscopic polyangitis (MPA), eosinophilic granulomatosis with polyangitis (EGPA formely Churg-Strauss Syndrome). This article reviews the treatment of them, according to EULAR (European League Against Rheumatism) recommendations, which are based on stage and severity of disease, including induction and maintance therapy, and therapy of refractory disease
Search on Google
Index:
LILACS (Americas)
Main subject:
Vasculitis
/
Antibodies, Antineutrophil Cytoplasmic
Type of study:
Practice guideline
Limits:
Female
/
Humans
/
Male
Language:
Portuguese
Journal:
Pulmäo RJ
Journal subject:
Pulmonary Disease (Specialty)
Year:
2014
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Estadual do Rio de Janeiro/BR
Similar
MEDLINE
...
LILACS
LIS